CITIGROUP INC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 82 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q1 2021$4,000
-76.5%
1,283
-77.9%
0.00%
Q4 2020$17,000
+88.9%
5,802
+33.8%
0.00%
Q3 2020$9,000
-25.0%
4,337
+64.0%
0.00%
Q2 2020$12,000
-77.8%
2,645
-59.6%
0.00%
Q1 2020$54,000
-26.0%
6,554
+64.3%
0.00%
Q4 2019$73,000
+160.7%
3,988
+57.8%
0.00%
Q3 2019$28,000
-48.1%
2,527
-52.9%
0.00%
Q2 2019$54,000
+63.6%
5,366
-3.3%
0.00%
Q1 2019$33,0000.0%5,550
+20.0%
0.00%
Q4 2018$33,000
-2.9%
4,626
-4.5%
0.00%
Q3 2018$34,000
+30.8%
4,845
+110.1%
0.00%
Q1 2018$26,000
+333.3%
2,306
+229.4%
0.00%
Q4 2017$6,000
+500.0%
700
+669.2%
0.00%
Q2 2017$1,00091
+1720.0%
0.00%
Q1 2016$0
-100.0%
5
-93.2%
0.00%
Q2 2015$1,000740.00%
Other shareholders
RECRO PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders